10-Q: Health In Tech Reports Soaring Revenue, Profit Growth

Health In Tech, Inc. announced significant revenue and profit growth for the first half of 2025, driven by new product demand and increased enrolled employees.

Summary

• Total revenues for the six months ended June 30, 2025, reached $17.3 million, a 71.1% increase from $10.1 million in the same period of 2024.
• Net income for the six months ended June 30, 2025, was $1.1 million, up 157.5% from $0.4 million in the prior year period.
• Adjusted EBITDA increased by 146.0% to $2.8 million for the six months ended June 30, 2025, compared to $1.1 million in 2024, with the Adjusted EBITDA margin improving to 16.1% from 11.2%.
• The number of enrolled employees (EEs) increased by 30% to 24,839 as of June 30, 2025, from 19,101 in the same period of 2024.
• Revenues from underwriting modeling (ICE) grew 29.8% to $4.4 million, while revenues from fees (SMR) surged 151.3% to $12.9 million for the six months ended June 30, 2025.
• HI Card revenue, previously a component of revenues from fees, was $0 for the three and six months ended June 30, 2025, compared to $767,840 and $1,575,214 respectively in 2024.
• Cost of revenues increased to 32.7% of total revenues for the six months ended June 30, 2025, up from 19.4% in the prior year, primarily due to higher captive management fees.
• General and administrative expenses increased to 40.5% of revenue for the six months ended June 30, 2025, from 37.7% in 2024, mainly due to increased public company costs and stock-based compensation.
• A refund liability of $955,743 was recorded for the six months ended June 30, 2025, related to a potential adjustment in underwriting modeling revenue for one carrier, with finalization expected in May 2026.
• The company purchased an additional $17.4 million in Deferred Administrative Surplus collection rights for $3.48 million on March 18, 2025, increasing other receivables to $3.85 million.
• Cash and cash equivalents increased to $8.1 million as of June 30, 2025, from $7.8 million at December 31, 2024, with net cash provided by operating activities rising to $2.0 million from $0.6 million.

Sentiment

Score: 8

Explanation: The company demonstrates strong financial performance with significant revenue, net income, and Adjusted EBITDA growth, coupled with increased enrolled employees and strategic partnerships. While there are concerns regarding the disappearance of HI Card revenue, increased cost of revenues as a percentage of revenue, and a refund liability, the overall growth trajectory and strategic initiatives are highly positive.

Positives

• Achieved substantial revenue growth of 71.1% year-over-year for the first half of 2025, reaching $17.3 million.
• Reported a significant increase in net income by 157.5% to $1.1 million for the six months ended June 30, 2025.
• Adjusted EBITDA grew by 146.0% to $2.8 million, demonstrating strong operational performance and margin expansion.
• Increased the number of enrolled employees by 30% to 24,839, indicating strong market penetration and adoption of solutions.
• Experienced strong demand for new product offerings, supported by positive feedback from beta testing with mid-to-large employers.
• Formed strategic partnerships with key industry players including Verdegard Administrators (MedImpact), Unified Health Plans, HILB Group, and Baily Insurance.
• Appointed Edward T. McMullen Jr., former U.S. Ambassador, to the advisory board, enhancing strategic insight and network.
• Improved efficiency in sales and marketing expenses, which decreased as a percentage of revenue from 19.9% to 13.4% for the six months ended June 30, 2025.
• Research and development expenses decreased as a percentage of revenue from 14.4% to 6.5%, reflecting capitalization of development costs for eDIYBS 3.0.
• Net accounts receivable decreased by $365,972 due to process enhancements and automation of the AR system.
• Net cash provided by operating activities increased significantly by $1.4 million to $2.0 million for the six months ended June 30, 2025.

Negatives

• HI Card revenue, a component of fees, dropped to $0 for the three and six months ended June 30, 2025, indicating a discontinuation or significant shift in this service line.
• Cost of revenues as a percentage of total revenues increased significantly from 19.4% to 32.7% for the six months ended June 30, 2025, primarily due to higher captive management fees.
• General and administrative expenses increased as a percentage of revenue from 37.7% to 40.5% for the six months ended June 30, 2025, driven by increased public company costs and stock-based compensation.
• A refund liability of $955,743 was recorded for the six months ended June 30, 2025, related to a potential adjustment in underwriting modeling revenue for one carrier, introducing uncertainty until May 2026.
• The significant increase in 'Other receivables' due to purchasing collection rights for Deferred Administrative Surplus introduces collection risk, despite the discounted purchase price.

Risks

• Ability to obtain funding for operations, system enhancements, and development of additional functionalities.
• Success, cost, and timing of system offering development activities.
• Ability to establish sales, marketing, and distribution infrastructure to commercialize any drug candidates for which approval is obtained.
• Ability to attract and retain key personnel and necessary qualified employees to expand operations.
• Ability to attract new customers to utilize platforms and successfully monetize products and services.
• Impact of competition in the industry and innovation by competitors.
• Risks related to cybersecurity incidents or other network disruptions.
• Risks related to the use of third-party artificial intelligence.
• Ability to stay abreast of and comply with new or modified laws and regulations, including those related to insurance services and data privacy.
• Ability to protect intellectual property rights and maintain and build the brand.
• Fluctuations in the future trading prices of Class A common stock.
• Potential claims relating to intellectual property.
• Concentration of revenues from a single stop-loss insurance carrier (Carrier A accounted for 28.3% of total revenues for the six months ended June 30, 2025).
• Concentration of cost of revenues with three primary service providers (accounting for 78.8%, 6.4%, and 5.2% of cost of revenues for the six months ended June 30, 2025).
• Concentration of data service providers from third-party Artificial Intelligence providers (one provider accounted for 6.4% of cost of revenues for the six months ended June 30, 2025).
• Failure to accurately perform underwriting procedures could result in increased costs, higher pricing for health plans, and reputational harm to the eDIYBS platform.
• Seasonality of enrollment and medical expenses, which may become more pronounced if the rapid growth rate slows.

Future Outlook

The company expects to continue its growth by expanding its network of brokers, TPAs, MGUs, and other third-party agents, entering into more collaborations with insurance carriers, and offering new products and plans. It plans to continue investing in technology and innovation to drive advancements in automation and enhance operational efficiency. The final amount of a significant revenue adjustment for one carrier's underwriting modeling revenue is expected to be finalized in May 2026, with quarterly updates to the estimate.

Management Comments

• In the first half of 2025, we achieved 71% year-over-year revenue growth compared to the same period in 2024, while maintaining healthy profitability.
• Our business growth will depend on our ability to collaborate with a diverse range of insurance carriers to service the excess coverage needs of our clients.
• Our growth strategy is heavily reliant on our capability to introduce innovative insurance products and plans.
• Our growth is significantly dependent on our ability to accurately perform underwriting procedures and maintain strong relationships with brokers, TPAs, carriers, MGUs, and other third-party agents who utilize our platforms.
• Our ongoing commitment to investing in technology is crucial for driving advancements in automation and enhancing operational efficiency across all aspects of our business. We are dedicated to regularly updating and developing new technology.

Industry Context

Health In Tech operates within the rapidly evolving InsurTech sector, focusing on digital transformation and automation in healthcare insurance. Its platform-based approach, streamlining processes for brokers, TPAs, and carriers, aligns with the broader industry trend towards efficiency and cost reduction in self-funded benefits plans. The company's emphasis on medical underwriting and machine learning reflects the increasing adoption of advanced technologies to assess risk and customize health plans. Strategic partnerships with established players like MedImpact and large insurance brokers indicate a move towards deeper integration within the healthcare ecosystem to expand market reach and service offerings.

Management Changes

Legal Proceedings

• Not presently party to any legal proceedings the resolution of which is believed to have a material adverse effect on business, prospects, financial condition, liquidity, results of operation, cash flows or capital levels.

Stakeholder Impact

• Shareholders: Positive impact due to strong revenue and profit growth, increased equity, and strategic partnerships, potentially leading to increased share value.
• Employees: Potential positive impact from growth and expansion, but also increased stock-based compensation, which can dilute existing shares.
• Customers (small business employers, insurance carriers): Positive impact through new product offerings, cost savings, and streamlined processes, but potential negative impact from increased premiums if underwriting procedures are inaccurate or if the refund liability impacts future pricing.
• Brokers, TPAs, MGUs, and other third-party agents: Continued and expanded business opportunities through the company's platform and new collaborations.
• Service Providers: Increased business volume due to expanded operations, particularly for captive management and data service providers, but also concentration risk for the company if these relationships are disrupted.

Next Steps

• Continue to expand the network of brokers, TPAs, MGUs, and other third-party agents.
• Enter into more collaborations with insurance carriers to broaden product and service portfolio.
• Introduce innovative insurance products and plans to meet client requirements and maintain competitiveness.
• Continue investment in technology and innovation to drive advancements in automation and enhance operational efficiency, particularly with eDIYBS 3.0.
• Monitor and update the estimate for the underwriting modeling revenue adjustment, with finalization expected in May 2026.

Key Dates

Recommendation

The company demonstrates exceptional top-line and bottom-line growth, with revenues up 71.1% and net income up 157.5% year-over-year for the first half of 2025. The significant increase in enrolled employees and strategic partnerships with major industry players indicate strong market traction and future expansion potential. While there are some concerns regarding the increased cost of revenues as a percentage of revenue and the disappearance of HI Card revenue, these are outweighed by the robust overall financial performance and strategic positioning in a growing InsurTech market. The company's continued investment in technology and focus on efficiency are positive long-term indicators, making it an attractive 'buy' for growth-oriented investors.

Keywords

InsurTech, Health Insurance, Self-Funded Benefits, Stop-Loss Insurance, Underwriting, Healthcare Technology, SaaS, Financial Results, SEC Filing, Quarterly Report, Q2 2025, Insurance Marketplace, AI, eDIYBS